Allan Rasmussen
Overview
Explore the profile of Allan Rasmussen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dos Santos Q, Leung P, Thorball C, Ledergerber B, Fellay J, MacPherson C, et al.
Front Mol Biosci
. 2023 Dec;
10:1282412.
PMID: 38131015
Type 2 diabetes mellitus (T2DM) can be multifactorial where both genetics and environmental factors play a role. We aimed to investigate the use of polygenic risk scores (PRS) in the...
12.
Hegland N, Rezahosseini O, Pedersen C, Moller D, Bugge T, Wareham N, et al.
APMIS
. 2023 Dec;
132(3):152-160.
PMID: 38084017
Information about anemia in liver transplant (LTx) recipients is scarce. We investigated the prevalence and severity of anemia before and within the first-year post-LTx, risk factors for having anemia before...
13.
Harboe Z, Hald A, Ekenberg C, Wareham N, Lundbo L, Gitz Holler J, et al.
Vaccine
. 2023 Sep;
41(45):6637-6644.
PMID: 37775467
Vaccination is an evidence-based strategy to prevent or reduce the severity of infectious diseases (ID). Here, we aimed to describe the experience of implementing a vaccination clinic specifically targeting liver,...
14.
Aberg F, Sallinen V, Tuominen S, Adam R, Karam V, Mirza D, et al.
J Hepatol
. 2023 Sep;
80(1):99-108.
PMID: 37722533
Background & Aims: There is controversy regarding the optimal calcineurin inhibitor type after liver transplant(ation) (LT) for primary sclerosing cholangitis (PSC). We compared tacrolimus with cyclosporine in a propensity score-matched...
15.
Moller D, Schwartz Sorensen S, Rezahosseini O, Rasmussen D, Arentoft N, Loft J, et al.
Front Immunol
. 2023 Jul;
14:1183703.
PMID: 37465673
Introduction: Herpes virus infections are a major concern after solid organ transplantation and linked to the immune function of the recipient. We aimed to determine the incidence of positive herpes...
16.
Nissen T, Rechnitzer C, Albertsen B, Borgwardt L, Christensen V, Fallentin E, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444465
Background: Malignant liver tumours in children are rare and national outcomes for this tumour entity are rarely published. This study mapped paediatric liver tumours in Denmark over 35 years and...
17.
Suarez-Zdunek M, Saini S, Pedersen C, Hamm S, Hald A, Rasmussen A, et al.
BMC Infect Dis
. 2023 Apr;
23(1):214.
PMID: 37024811
Background: Life-long immunosuppressive treatment after liver transplantation (LT) prevents graft rejection but predisposes the LT recipient to infections. Herpesvirus infections are associated with morbidity and mortality among LT recipients. Among...
18.
Arentoft N, Moller D, Knudsen A, Abdulovski R, Kirkby N, Schwartz Sorensen S, et al.
Microbiol Spectr
. 2023 Mar;
:e0322622.
PMID: 36976014
Influenza is a common respiratory tract infection in solid organ transplant (SOT) recipients. We aimed to investigate the incidence, risk factors, and complications of influenza in a large cohort of...
19.
Bergsmark T, Engesaeter L, Rasmussen A, Bennet W, Nordin A, Pall V, et al.
Scand J Gastroenterol
. 2023 Mar;
58(8):923-930.
PMID: 36872559
Objectives: Alcohol-related liver disease (ALD) is among the most common indications for liver transplantation (LTX) in Europe and North America, with good five-year survival rates post-LTX. Here we evaluated survival...
20.
Rezahosseini O, Hamm S, Heftdal L, Perez-Alos L, Moller D, Perch M, et al.
Front Immunol
. 2023 Jan;
13:1075423.
PMID: 36713395
Introduction: We investigated humoral and T-cell responses within 12 months after first BNT162b2 vaccine in solid organ transplant (SOT) recipients and controls who had received at least three vaccine doses....